In another study, Li et al. investigated an anti-IL-8 antibody in a humanized pancreatic cancer mouse model [44], finding enhanced myeloid cell activation and potentiation of the antitumor activity of an anti-PD-1 antibody. This evidence concerns the gene CXCL8 and familial pancreatic carcinoma.